Combating Illicit Xylazine Act

Read twice and referred to the Committee on the Judiciary.

Bill 119 s 545, also known as the "Xylazine Prohibition Act," aims to restrict the use of xylazine for certain purposes. Xylazine is a sedative commonly used in veterinary medicine, but it has also been misused as a recreational drug, particularly in combination with opioids.

The bill prohibits the use of xylazine for non-medical purposes, such as recreational drug use or as an adulterant in illicit substances. It also imposes penalties for those found in violation of the prohibition, including fines and potential imprisonment.

The legislation is intended to address the growing concern over the misuse of xylazine and its potential dangers to public health. Supporters of the bill argue that restricting access to xylazine for non-medical purposes will help prevent overdoses and other negative health outcomes associated with its misuse. Opponents of the bill may argue that it could limit access to xylazine for legitimate medical purposes, potentially impacting veterinary care. However, the bill includes provisions to ensure that xylazine remains available for veterinary use under appropriate circumstances. Overall, Bill 119 s 545 seeks to strike a balance between addressing the misuse of xylazine and ensuring that it remains available for necessary medical purposes. It reflects a growing recognition of the need to address the misuse of certain substances and protect public health.